Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0P3SH
|
||||
Former ID |
DIB004851
|
||||
Drug Name |
ReN-1826
|
||||
Synonyms |
Neurotrophin receptor program, Enact; Neurotrophin receptor program, ReNeuron
|
||||
Indication | Central nervous system disease [ICD10:G00-G99] | Terminated | [547600] | ||
Company |
University of Bristol
|
||||
Target and Pathway | |||||
Target(s) | Neurotrophin-4 ligand | Target Info | Inhibitor | [528418] | |
Neurotrophin-3 | Target Info | Inhibitor | [528418] | ||
NetPath Pathway | TNFalpha Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.